GlassScriptPhysician profile
Amy Beth Wertman
NPI 1669470738
$2,552.15
in general payments reported to CMS, 2019-2025
30 companies · $892 in 2025
The $892 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $265 · 2023: $634 · 2024: $541 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $441.44 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $296.53 | 2021-2024 | Myrbetriq, Xtandi, Veozah |
| Abbvie INC. | $218.10 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $191.53 | 2021-2025 | |
| Medtronic, INC. | $180.04 | 2021-2023 | Interstim |
| Bioprotect Medical, INC. | $144.38 | 2024-2025 | Bioprotect Balloon Implant System |
| Tolmar, INC. | $110.17 | 2023-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $106.05 | 2023-2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $88.11 | 2023-2025 | Pylarify |
| Urogen Pharma, INC. | $77.13 | 2025 | |
| Boston Scientific Corporation | $77.06 | 2023-2024 | Ams 700, Spaceoar System, Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $66.66 | 2025 | |
| Immunitybio, INC. | $62.98 | 2024-2025 | |
| Olympus America INC. | $55.59 | 2024-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $52.73 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $49.81 | 2024-2025 | Lynparza |
| Teleflex LLC | $46.30 | 2021-2023 | Urolift |
| Amgen INC. | $39.18 | 2021 | |
| Accord Healthcare, INC. | $36.19 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $27.71 | 2025 | Keytruda |
| Photocure INC | $27.31 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $24.17 | 2021 | |
| Pfizer INC. | $22.45 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $20.45 | 2022 | |
| Coloplast Corp | $16.10 | 2025 | |
| Laborie Medical Technologies Corp. | $16.04 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Clovis Oncology, INC. | $15.31 | 2021 | |
| Mission Pharmacal Company | $14.91 | 2022 | |
| Avation Medical, INC. | $14.40 | 2025 | Vivally System |
| Procept Biorobotics Corporation | $13.32 | 2024 | Aquabeam System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wertman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.